Trials / Completed
CompletedNCT03866928
Pharmacokinetic Study of Stiripentol and Its Metabolites After Multiple Dose Oral Administration in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Biocodex · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a monocentric open label study to assess the PK parameters of stiripentol and its metabolites (if any are detected) after multiple oral doses in 14 healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Stiripentol | 1500 mg of stiripentol b.i.d. |
Timeline
- Start date
- 2019-02-12
- Primary completion
- 2019-04-05
- Completion
- 2019-04-05
- First posted
- 2019-03-07
- Last updated
- 2019-12-20
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03866928. Inclusion in this directory is not an endorsement.